Presentation given at MoMoAMS #14 on jan,25 2010
http://www.mobilemonday.nl/
More info here: http://zorgbeheer.blogspot.com/2010/01/mhealth-is-huge-momoams-14-about-mobile.html
World’s first one wrist ecg band and other revolutionary products from Europe’s fastest growing biotech company in $142b market investment opportunity with 28x return in 3 years
Utilizing wearable technology in remote patient monitoring with aging populat...Valencell, Inc
Most developed nations are experiencing a dramatic aging of the population, which is putting pressure our healthcare systems to provide care outside of medical facilities and driving opportunities for remote patient monitoring systems. In fact, 90% of family caregivers want a way to monitor their loved ones, receive alerts and be involved in their care. This webinar will discuss the trends driving remote patient monitoring today and how these systems are utilizing wearable technology to elevate the level of care possible outside of medical facilities. You won’t want to miss this webinar!
While E-health is based on networked I-C-T devices of the humans, operated by the humans for human healthcare and wellness, IOMT is a network of the ‘smart-devices’, operated by the devices for human healthcare and wellness. An estimated 160 million smart medical devices are expected to be connected in 2020. This number will increase exponentially. We need to be prepared for the disruptive influence of IOMT on the present-day healthcare paradigm. A major concern is the sheer magnitude of digital healthcare data generated by IOMT. Are we creating a "Digital Black hole" is a question for deep introspection.
Non Invasive Health Monitoring with mHealthBart Collet
mHealth Trends and examples of non invasive mobile health devices, organisations and services.
Made as preparation for MoMoAMS #14 about mHealth, Jan 25th 2010, Amsterdam
PPT Presentation for All Clear Diagnostics, Inc. to prospective investors that demonstrates how their product, ClearECG for MRI, fulfills unmet needs in what represents a very lucrative investment opportunity.
mHealth Israel_Anne LeGrand_IBM Watson_Big Data in HealthcareLevi Shapiro
Presentation by Anne LeGrand, VP Imaging, IBM Watson HEALTH: Big Data in Healthcare. Includes a future with AI; Industry Challenges; Natural Language Processing; Deep Learning; Make the Invisible, Visible; Accelerating the Pace of Drug Discovery; Become a Trusted Advisor; Treatment Recommendations by Cognitive Computing; Derive Actionable Insights; Managing Care and Improving Lives; Identifying Outcomes of Precision Cohorts; Diabetes; Medical Imaging; Market Size; AI Value; Imaging AI Market; How to Set Priorities; Safety Net; Global Issues; Watson Health Imaging Strategy; Maturity Curve; Precision Medicine; Watson Imaging Clinical Review; Key Principles;
Wearable biosensors for glucose monitoring specially, Continuous glucose monitoring devices have come a long way since the introduction of first and second generation of sensors. The trend continues as there is more than ever increasing requirement for self-monitoring equipment and development of appropriate glucose biosensors to congregate the demands of the patients afflicted with this extremely rampant disorder.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Presentation given at MoMoAMS #14 on jan,25 2010
http://www.mobilemonday.nl/
More info here: http://zorgbeheer.blogspot.com/2010/01/mhealth-is-huge-momoams-14-about-mobile.html
World’s first one wrist ecg band and other revolutionary products from Europe’s fastest growing biotech company in $142b market investment opportunity with 28x return in 3 years
Utilizing wearable technology in remote patient monitoring with aging populat...Valencell, Inc
Most developed nations are experiencing a dramatic aging of the population, which is putting pressure our healthcare systems to provide care outside of medical facilities and driving opportunities for remote patient monitoring systems. In fact, 90% of family caregivers want a way to monitor their loved ones, receive alerts and be involved in their care. This webinar will discuss the trends driving remote patient monitoring today and how these systems are utilizing wearable technology to elevate the level of care possible outside of medical facilities. You won’t want to miss this webinar!
While E-health is based on networked I-C-T devices of the humans, operated by the humans for human healthcare and wellness, IOMT is a network of the ‘smart-devices’, operated by the devices for human healthcare and wellness. An estimated 160 million smart medical devices are expected to be connected in 2020. This number will increase exponentially. We need to be prepared for the disruptive influence of IOMT on the present-day healthcare paradigm. A major concern is the sheer magnitude of digital healthcare data generated by IOMT. Are we creating a "Digital Black hole" is a question for deep introspection.
Non Invasive Health Monitoring with mHealthBart Collet
mHealth Trends and examples of non invasive mobile health devices, organisations and services.
Made as preparation for MoMoAMS #14 about mHealth, Jan 25th 2010, Amsterdam
PPT Presentation for All Clear Diagnostics, Inc. to prospective investors that demonstrates how their product, ClearECG for MRI, fulfills unmet needs in what represents a very lucrative investment opportunity.
mHealth Israel_Anne LeGrand_IBM Watson_Big Data in HealthcareLevi Shapiro
Presentation by Anne LeGrand, VP Imaging, IBM Watson HEALTH: Big Data in Healthcare. Includes a future with AI; Industry Challenges; Natural Language Processing; Deep Learning; Make the Invisible, Visible; Accelerating the Pace of Drug Discovery; Become a Trusted Advisor; Treatment Recommendations by Cognitive Computing; Derive Actionable Insights; Managing Care and Improving Lives; Identifying Outcomes of Precision Cohorts; Diabetes; Medical Imaging; Market Size; AI Value; Imaging AI Market; How to Set Priorities; Safety Net; Global Issues; Watson Health Imaging Strategy; Maturity Curve; Precision Medicine; Watson Imaging Clinical Review; Key Principles;
Wearable biosensors for glucose monitoring specially, Continuous glucose monitoring devices have come a long way since the introduction of first and second generation of sensors. The trend continues as there is more than ever increasing requirement for self-monitoring equipment and development of appropriate glucose biosensors to congregate the demands of the patients afflicted with this extremely rampant disorder.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
3. The Current State Health Services
The Healthcare System is
Imploding While Spending
Rises
Worldwide Today
– 1 billion overweight
– 860 million chronic disease
– 600 million elders
– 75-85% chronic disease spending
– 200K hospitals, 18 million hospital
beds
Healthcare Spending
– US: $2.1 trillion in 2006
• Home Health care is the fastest
growing segment
– World: $4.1 trillion in 2004
* http://ucatlas.ucsc.edu/spend.php
QUALCOMM PROPRIETARY Health & Life Sciences 3
4. The US Health Care Opportunity
• Employers are willing to
pay for solutions that will
reduce healthcare costs
and enhance employee
wellness
– Intel is paying over $1 billion this
year in related costs*
• There is an established
consumer market for
personalized healthcare,
consumer health, and
fitness services
* David Whitlinger, Continua President and Chair of the Board of Directors
QUALCOMM PROPRIETARY Health & Life Sciences 4
5. Growth Area - CDHP
QUALCOMM PROPRIETARY Health & Life Sciences 5
6. SMART Wireless HealthSM Vision
Smart Medical Applied Radio Technologies
• Consumers will Manage Their Own Wellness
• Bio-sensors and Mobile Devices
Provide Health Feedback
Wireless Band AId Mobile Phones
ECG Sensor
• Mobile Networks Gateways for Remote Care
For consumers, caregivers, healthcare providers, family members, health and fitness coaches
QUALCOMM PROPRIETARY Health & Life Sciences 6
8. • The Alliance focuses on wireless cellular technologies enabling new
business models and business process improvements in all sectors of
the life sciences industries.
• San Diego is at the heart of the world's wireless and life sciences
technology markets - over 1200 companies; a great focal point for the
convergence of wireless technologies, the life sciences and consumers.
QUALCOMM PROPRIETARY Health & Life Sciences 8
10. Wireless Health Innovation & Partnering
Body
EKG Blood Peak
Activi
• SMART Devices Weigh
monit Pressure Flow
ty
t
or
• SMART Pills
• SMART Band-AidsTM Auscu Inhalation
• SMART Body Sensors ltation Registration
• SMART Implanted
Sensors
• SMART Health Mobiles Pill Body
• SMART Tele-Presence Box Temperat
Blood ure
• SMART Collaboration Heart
Glucose
Rate
QUALCOMM PROPRIETARY Health & Life Sciences 10
11. Qualcomm’s Wireless Health Portfolio
New Devices and Services
• SMART Wireless Health
– SMART Medical Devices
• CardioNet
– Smart Band-Aids™
• Triage Wireless
– SMART In Vivo Body Networks
• CardioMems
• SMART Managed Wireless Services
– Hobson: Collaboration Service
– QConnect: Managed Services
– LifeCOMM: Personal Health
Management ‘Converged’ Wireless
Medical Devices, Biosensors in
Consumer Mobile Handsets
– Myca & InTouch Health: Co-
development in Virtual Tele-Presence
QUALCOMM PROPRIETARY Health & Life Sciences 11
12. Bodies & Organs as ‘Nodes on the Net’ – Body Area
Networks (BAN) - Ultimate Network for Diagnostics
• SMART Band-Aids™
Make measurements from skin or read
in vivo sensors
• SMART Implanted Sensors
Provide the ultimate bio-physiological
feedback
– CardioMEMS monitors Blood
Pressure inside the aorta today
– Biotronik monitors Pacemakers
– Nano technology will allow tracking
of chemical bio-markers in the future
• SMART Mobile Devices
Relay information from SMART Band
Aids™ and Implanted SMART Sensors
to remote servers via the Internet
QUALCOMM PROPRIETARY Health & Life Sciences 12
13. CardioNet - Built on SMART Services
AT HOME OR AWAY DAILY,
HEARTBEAT BY 24/7/365
URGENT AND
HEARTBEAT
SUMMARY
PROPRIETARY
AUTOMATED EVENT DETECTION
SURVEILLANCE REPORTS
SOFTWARE
SYMPTOMATIC EVENTS
RATE, RHYTHM, INTERNET,
IDTF PHONE, FAX
MORPHOLOGY AUTOMATIC CELL OR LANDLINE
REPORT
ALGORITHM ECG FETCH
TRANSMISSION-NO PATIENT DELIVERY
INTERVENTION
MD NOTIFICATION TEXT
CRITERIA MESSAGES
96 HOURS OF ECG STORAGE
QUALCOMM PROPRIETARY Health & Life Sciences 13
14. Life service package
Healthcare
Lease health communication devices
devices
Cellular communication service
ASP information management service.
Pedometer (Omron Healthcare Co.)
HJ-710IT
Wireless communication device
Body composition meter
(Omron Healthcare Co.)
KDDI HBF-354IT
Network
Blood pressure monitor
(Omron Healthcare Co.)
HEM-7080IC
USB
CDMA1X
Module inside
connection
Glucose meter
Data Management Service Johnson & Johnson
One Touch UltraTM
QUALCOMM PROPRIETARY Health & Life Sciences 14
15. New Business Model - Server-Based Diagnostics
N
WA
W
Server-based Computing
Leads WLAN
Patients
Wireless Diagnostic
Sensors
In-Room or On-
Sensor Display EMR SMART Fax Printer PC
Mobile
QUALCOMM PROPRIETARY Health & Life Sciences 15
16. HOBSON: Solving the ‘healthcare asynchronous
communication problem’
• Patient care involves the interaction of many healthcare professionals
who rely on unreliable, cumbersome communication tools including:
– Paging
– Fax
– Voice Mail
– Text Messaging
– E-mail
– Phone calls
• Time lost dealing with
delays of outmoded systems
• Missed or idle messages go
unanswered delaying care
HOBSON is a intelligent, prioritized, multi-media messaging
service, optimized for care team communication and responsive to
the preferences of the individual care team member.
QUALCOMM PROPRIETARY Health & Life Sciences 16
17. LifeCOMM Virtual & Live Assistance
Solution Specific
Solution Specific Handsets Live Assistants
Subscriber
Consultation
Consultation Escalation
by Virtual Assistant
or Subscriber Request
Subscriber data
access and updates
Personal health
information and
data
Educational info, test
reminders, food intake,
Subscriber data
suggested therapy
access (incl. logbook)
actions, etc.
Solution Specific & personal info updates
‘Virtual Assistant’’
User, Caregiver and Provider Portals
Expert System
QUALCOMM PROPRIETARY Health & Life Sciences 17
18. Virtual Tele-Presence Today
Leveraging Wireless Systems to Improve Health
• Wireless Industry Is In
a Unique Position to
Revolutionize Health
Services
• 3G Networks Provide
High Throughput &
High Capacity
Connectivity
QUALCOMM PROPRIETARY Health & Life Sciences 18
19. SMART Health is Mobile
QUALCOMM PROPRIETARY Health & Life Sciences 19
20. Qualcomm
Wireless Health
SMARTSM Innovation & Partnership
02.14.2008
QUALCOMM PROPRIETARY 20
Health & Life Sciences
